AprilBio Co.,Ltd. (KOSDAQ:397030)

AprilBio Statistics

Total Valuation

AprilBio has a market cap or net worth of KRW 884.16 billion. The enterprise value is 794.46 billion.

Market Cap	884.16B
Enterprise Value	794.46B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

AprilBio has 22.97 million shares outstanding. The number of shares has increased by 3.96% in one year.

Current Share Class	22.97M
Shares Outstanding	22.97M
Shares Change (YoY)	+3.96%
Shares Change (QoQ)	-1.45%
Owned by Insiders (%)	30.45%
Owned by Institutions (%)	16.60%
Float	15.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	98.52
PB Ratio	9.78
P/TBV Ratio	9.86
P/FCF Ratio	281.13
P/OCF Ratio	254.54
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-905.23
EV / Sales	88.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	252.61

Financial Position

The company has a current ratio of 14.63, with a Debt / Equity ratio of 0.02.

Current Ratio	14.63
Quick Ratio	14.56
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	0.63
Interest Coverage	-1.96

Financial Efficiency

Return on equity (ROE) is -1.07% and return on invested capital (ROIC) is -1.16%.

Return on Equity (ROE)	-1.07%
Return on Assets (ROA)	-1.04%
Return on Invested Capital (ROIC)	-1.16%
Return on Capital Employed (ROCE)	-1.78%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +116.22% in the last 52 weeks. The beta is 1.69, so AprilBio's price volatility has been higher than the market average.

Beta (5Y)	1.69
52-Week Price Change	+116.22%
50-Day Moving Average	31,083.00
200-Day Moving Average	21,014.40
Relative Strength Index (RSI)	62.27
Average Volume (20 Days)	1,306,416

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AprilBio had revenue of KRW 8.97 billion and -877.63 million in losses. Loss per share was -38.99.

Revenue	8.97B
Gross Profit	8.95B
Operating Income	-1.62B
Pretax Income	-877.63M
Net Income	-877.63M
EBITDA	-923.76M
EBIT	-1.62B
Loss Per Share	-38.99

Balance Sheet

The company has 91.70 billion in cash and 1.99 billion in debt, giving a net cash position of 89.71 billion or 3,906.16 per share.

Cash & Cash Equivalents	91.70B
Total Debt	1.99B
Net Cash	89.71B
Net Cash Per Share	3,906.16
Equity (Book Value)	90.41B
Book Value Per Share	3,995.18
Working Capital	87.56B

Cash Flow

In the last 12 months, operating cash flow was 3.47 billion and capital expenditures -328.51 million, giving a free cash flow of 3.15 billion.

Operating Cash Flow	3.47B
Capital Expenditures	-328.51M
Free Cash Flow	3.15B
FCF Per Share	136.95

Margins

Gross margin is 99.79%, with operating and profit margins of -18.00% and -9.78%.

Gross Margin	99.79%
Operating Margin	-18.00%
Pretax Margin	-9.78%
Profit Margin	-9.78%
EBITDA Margin	-10.29%
EBIT Margin	-18.00%
FCF Margin	35.05%

Dividends & Yields

AprilBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.96%
Shareholder Yield	-3.96%
Earnings Yield	-0.10%
FCF Yield	0.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 31, 2023. It was a forward split with a ratio of 2.

Last Split Date	Oct 31, 2023
Split Type	Forward
Split Ratio	2

Scores

AprilBio has an Altman Z-Score of 38 and a Piotroski F-Score of 3.

Altman Z-Score	38
Piotroski F-Score	3